GVR Report cover Non-invasive Aesthetic Treatment Market Size, Share & Trends Report

Non-invasive Aesthetic Treatment Market Size, Share & Trends Analysis Report By Procedure (Skin Rejuvenation, Injectables), By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Dec, 2020
  • Base Year for Estimate: 2020
  • Report ID: GVR-4-68038-034-7
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 110

Report Overview

The global non-invasive aesthetic treatment market size was valued at USD 4.6 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 13.9% from 2021 to 2028. The market growth is attributed to the rising demand for fillers and injectables including Botox as a result of the increasing target population across the globe. According to the American Society for Aesthetic Plastic Surgery (ASAPS), in 2018, around 3.8 million minimally invasive cosmetic surgeries were carried out in the U.S. within the age group of 55 and above. This highlights high growth prospects for the market in the country. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the U.S. was ranked first in terms of non-surgical procedures performed at a global level.

The U.S. non-invasive aesthetic treatment market size, by procedure, 2016 - 2028 (USD Million)

Of these, injectables, such as botulinum toxin and hyaluronic acid, were among the most popular procedures performed. The country is backed by advanced treatment options and has the highest number of surgeons at a global level. Growing awareness about fitness has increased the demand for non-invasive aesthetic treatment in developing countries. In countries, such as India, non-invasive aesthetic treatment is gaining consumer interest.

The country ranks among the top 5, in terms of surgical procedures performed. Thus, developing countries are expected to be key revenue pockets for the market in the years to come. The Covid-19 pandemic has significantly affected the non-invasive aesthetic treatment market. The cosmetics industry relies on close physical contact with their clients, leaving it negatively affected.

COVID19 impact: A 51.2% increase in demand was observed

Pandemic Impact

Post COVID Outlook

The non-invasive market increased by 51.2% from 2019 to 2020, as per earlier projections the market was expected to be over USD 7.2 Billion in 2020

The pandemic has resulted in an increase in virtual consultations since the advent of Covid. For instance, the British Association of Aesthetic Plastic Surgeons (BAAPS) reported that doctors in the UK witnessed up to 70% increases in requests for virtual consultations

The injectable market had the highest revenue of 8.8 billion in 2020 and will reciprocate the highest growth in the future. This lockdown might certainly act as a springboard and is expected to drastically increase patient footfall post-pandemic.

To help dermatology practices manage their finances better, companies are offering practitioners reliefs such as an extension on payment terms, a replacement for expired products, and discounts on complimentary skincare products to support patient engagement & prepare practices for a robust recovery

The manufacturing firms in Taiwan, South Korea, United States, and Israel had to decrease production for components of laser-based devices in the first and second quarter of 2020, which impacted the supply chain. This has led to a decrease in production launched as of 2020

There has been increased demand for home skincare devices during the pandemic. For instance, there has been an increase in sales of Philip’s at-home Intense Pulse Light (IPL) hair removal system, with strong demand in the APAC region


Practitioners have also raised concerns over the downturn in patients' interest owing to a sharp cut in income level. The market is expected to witness a phase of short-term negative growth. Companies are expected to address this by offering maximum support to their customers. For instance, leading player, Allergan, has assured support for its BOTOX® operations and patient assistance.

Procedure Insights

The injectables procedure segment led the market in 2020 and accounted for the largest share of over 62%. Injectables can be easily used by surgeons and provide faster treatment with quick results and less downtime as compared to others. The others segment include hair removal, non-surgical fat reduction, sclerotherapy, and cellulite treatment. Nonsurgical fat reduction is estimated to be the fastest-growing segment during the forecast period.

Laser hair removal is gaining popularity as it saves time and is more cost-effective compared to waxing, shaving, or hair removal creams. According to the International Society of Aesthetic Plastic Surgery (ISAPS), hair removal was among the top 5 nonsurgical procedures carried out at a global level in 2019. The skin rejuvenation procedure segment is expected to grow lucratively over the forecast period owing to the high efficiency of this procedure.

Regional Insights

North America held the largest revenue share of over 37% in 2020 owing to increasing demand for cosmetic procedures in the region. The growth in rates of cosmetic surgery procedures from the year 2000 to 2018 was compared by the American Society of Plastic Surgeons (ASPS). It was observed that the use of Botox injections increased by 845%. Thus, North America is expected to be a key revenue-generator for the global market in the coming years.

Global non-invasive aesthetic treatment market share, by region, 2020 (%)

Asia Pacific is projected to register the fastest CAGR of over 14% during the forecast period due to the growing population in countries, such as China, India, and Thailand. Moreover, increasing focus on physical appearance in these developing countries is expected to play a key role in augmenting the demand for non-invasive aesthetic treatments. Thailand is projected to be one of the fastest-growing countries in the APAC region during the forecast period.

Key Companies & Market Share Insights

Most of the companies focus on growth strategies, such as enhancements in the existing technologies, geographical expansion, product launches, and product approvals. Recently, in 2019, one of the key players, Allergan, had launched a TV ad campaign for its brand, Botox Cosmetics for millennials. According to the American Academy of Facial Plastic and Reconstructive Surgery, in the past five years, Botox injections have increased by 22%. Some of the key players in the global non-invasive aesthetic treatment market include:

  • Hologic, Inc.

  • Allergan, Inc.

  • Galderma S.A.

  • Alma Lasers

  • Syneron Candela

  • Johnson & Johnson

  • Merz Pharma

  • Lumenis

  • Solta Medical

  • Cutera, Inc.

  • Revance Therapeutics, Inc.

Non-invasive Aesthetic Treatment Market Report Scope

Report Attribute


Market size value in 2021

USD 8.45 billion

Revenue forecast in 2028

USD 18.5 billion

Growth Rate

CAGR of 13.9% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Procedure, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Norway; Sweden; China; Japan; India; South Korea; Thailand; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key companies profiled

Hologic, Inc.; Allergan, Inc.; Galderma S.A.; Alma Lasers; Syneron Candela; Johnson & Johnson; Merz Pharma; Lumenis; Solta Medical; Cutera, Inc.; Revance Therapeutics, Inc.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global non-invasive aesthetic treatment market report on the basis of procedure and region:

  • Procedure Outlook (Revenue, USD Million, 2016 - 2028)

    • Injectables

      • Botulinum Toxin

      • Calcium Hydroxylapatite

      • Hyaluronic Acid

      • Polymer Filler

      • Collagen

    • Skin Rejuvenation

      • Chemical Peel

      • Laser Skin Resurfacing

      • Photorejuvenation

    • Others

      • Hair Removal

      • Nonsurgical Fat Reduction

      • Sclerotherapy

      • Cellulite Treatment

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • Thailand

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.